The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.The manufacturer received information allegation of asthma (new or worsening), lung disease and leukocytosis.In addition, the customer reported allegations of nose irritation, respiratory tract irritation, inflammatory response, chest pain, dizziness and/or headache.The manufacturer was made aware of this complaint through a representative of the customer.Medical intervention was not specified.The manufacture's investigation is ongoing.A follow up report will be submitted when the manufacture's investigation is complete.
|